TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedPhase 4

Vigor and the LDR in Parkinson Disease

Parkinson disease (PD) is a common disorder in which reduced speed of movement results from inadequate brain production of the chemical dopamine. The most effective treatment for PD is the drug levo-dopa, which partially replaces brain dopa

Ann Arbor, Michigan, United StatesView details
TerminatedN/A

Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease

The purpose of this study is to examine the ability of a structured physical activity program to improve sleep quality and daytime sleepiness in patients with Parkinson's disease.

Chicago, Illinois, United StatesView details
CompletedEARLY_Phase 1

Development of Cognitive Assessment Tools in Parkinson Disease

The main objectives of this protocol are as follows: 1. To assess the sensitivity and specificity of ANAM-PD in detecting cognitive status in patients with Parkinson disease (PD) and healthy controls (HC).

New Haven, Connecticut, United StatesView details
Unknown

Parkinson's Research With Inclusion, Diversity and Equity

The purpose of this study is to identify the health and healthcare needs of LGBTQIA+ and non LGBTQIA+ communities living with Parkinson's disease.

Las Vegas, Nevada, United StatesView details
RecruitingEARLY_Phase 1

PET Imaging Evaluation of [11C]SY08

The overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies

Charlestown, Massachusetts, United StatesView details
UnknownN/A

Telemedicine Program in Parkinson's Disease (TELEPARK)

Parkinson's disease (PD) is a chronic neurodegenerative disease due to the loss of dopaminergic neurons in the substantia nigra, leading to motor symptoms of tremor, rigidity, and bradykinesia, as well as an array of non-motor symptoms that

Multiple locationsView details
CompletedN/A

Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease

Light treatment was originally employed in Parkinson's disease (PD) to determine if it might be effective in treating co-existing symptoms of depression and insomnia. However, a preliminary double-blind study as well as other studies report

Boston, Massachusetts, United States+2 moreView details
UnknownPhase 2

11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes

To evaluate the potential contribution of amyloid burden, as indexed by 11C-Pittsburgh compound B (PiB) retention, to the progression of cognitive impairments in patients with Parkinson's disease(PD).

Beijing, China+2 moreView details
Unknown

Correlation Between Non-motor Symptoms and Malnutrition in Patients With Parkinson's Disease

This study used Mini Nutrition Assessment (MNA) , Nutrition risk screening 2002(NRS-2002) and Non-motor Symptom Quest (NMSquest) to investigate the nutritional status of patients with Parkinson's disease, to analyze the correlation between

Hangzhou, Zhejiang, ChinaView details
TerminatedPhase 3

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

The purpose of this multi-center, randomized, double-blind, parallel-group, 26 week study is to compare the efficacy and safety of two different dose levels of Amantadine Extended Release Tablets to placebo for the treatment of levodopa ind

Tucson, Arizona, United States+55 moreView details
Completed

Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

The primary objective of this study is to estimate the incidence of new-onset valvulopathy, determined by baseline and follow-up echocardiograms, in patients with Parkinson's Disease who are receiving pergolide as second-line therapy. The s

Antwerp, Belgium+13 moreView details
Recruiting

Modifiable Variables in Parkinsonism (MVP)

We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and

Kenmore, Washington, United StatesView details
By invitationN/A

Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease

Background \& Rationale: Treatment options for Parkinson's Disease (PD) often face challenges due to the variety of clinical subtypes, differing individual responses, and disease progression. Given its portability, affordability, safety, a

Brussels, BelgiumView details
CompletedPhase 3

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

This randomized, multicenter, placebo-controlled, double-blind study will evaluate the efficacy and safety of inhaled CVT 301 compared with placebo in PD patients experiencing motor response fluctuations (OFF phenomena) as an outpatient (i.

Scottsdale, Arizona, United States+73 moreView details
Recruiting

French Parkinson's Disease Cohort - NS-PARK

The aim of NS-PARK cohort are to describe the natural history of Parkinson's disease (PD), and to propose patients stratification models based on PD pathophysiological mechanisms. Patients are included at all PD expert centers in France.

Paris, FranceView details
CompletedEARLY_Phase 1

Mobilaser Study to Help With People Who Are Having Problems With Their Gait

Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.

Jacksonville, Florida, United StatesView details
Active, not recruitingPhase 2

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a continuous SC infusion in subjects with advanced Parkinson's Disease (PD).

Phoenix, Arizona, United States+56 moreView details
UnknownPhase 1

Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)

Parkinson's disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. This study will investigate the use of far infrared radiation to manage, control and treat PD.

Toronto, Ontario, CanadaView details
Withdrawn

Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases

The etiology of many neurodegenerative diseases is unknown. A few studies have suggested the role of infection in the gastrointestinal tract in the etiology and pathogenesis of neurological diseases such as idiopathic Parkinson.

Charlotte, North Carolina, United StatesView details
CompletedPhase 2

Study of Tai Chi Exercise and Balance in Persons With Parkinson's Disease

Patients practicing Tai Chi will exhibit significant improvements in primary outcome measures of balance, and secondary outcomes of gait, physical performance, Unified Parkinson's Disease Rating Scale, Falls, muscle strength.

Eugene, Oregon, United StatesView details
Load more trials